RNA-protein interactions in unstable microsatellite diseases - PubMed (original) (raw)
Review
RNA-protein interactions in unstable microsatellite diseases
Apoorva Mohan et al. Brain Res. 2014.
Abstract
A novel RNA-mediated disease mechanism has emerged from studies on dominantly inherited neurological disorders caused by unstable microsatellite expansions in non-coding regions of the genome. These non-coding tandem repeat expansions trigger the production of unusual RNAs that gain a toxic function, which involves the formation of RNA repeat structures that interact with, and alter the activities of, various factors required for normal RNA processing as well as additional cellular functions. In this review, we explore the deleterious effects of toxic RNA expression and discuss the various model systems currently available for studying RNA gain-of-function in neurologic diseases. Common themes, including bidirectional transcription and repeat-associated non-ATG (RAN) translation, have recently emerged from expansion disease studies. These and other discoveries have highlighted the need for further investigations designed to provide the additional mechanistic insights essential for future therapeutic development.
Keywords: Bidirectional transcription; Microsatellite; Neurologic disease; Protein sequestration; RNA foci; RNA-mediated toxicity.
Copyright © 2014 Elsevier B.V. All rights reserved.
Figures
Fig. 1
Neuronal cell model illustrating pathogenic effects of non-coding microsatellite expansions in neurologic disease. Both sense (blue line) and antisense (red line) DNA repeat expansions result in three major downstream deleterious effects (labeled 1–3): (1) protein loss-of-function (LOF) results from hypermethylation of a CG-rich expanded microsatellite repeat in the 5′ UTR and/or promoter region of an affected gene and loss of transcriptional activity (e.g., FXS); (2) RNA gain-of-function (GOF) occurs following bidirectional transcription of expanded repeats and the synthesis of sense (sRNA) and antisense (asRNA), which fold into RNA hairpins (sRNA, blue; asRNA, red) or other stable structures and gain toxic functions either by sequestering an RNA binding protein(s) (RBP) and inhibiting pre-mRNA splicing (2a), pre-mRNA editing (2b), mRNA localization (2c), pri-miR processing (2d) or by triggering aberrant cellular activities such as protein kinase C (PKC) mediated CELF1 hyperphosphorylation (2e); (3) protein GOF due to altered post-translation modifications of other RNA binding proteins (3a) (CELF1 hyperphosphorylation, purple oval with white P in orange star) or RAN translation (3b) (three homopolymeric repeat proteins are shown with one undergoing translation by the ribosome (orange). In addition to these mechanisms, other pathways, including chromatin remodeling, proteome dysregulation and vesicular trafficking, may also contribute to disease pathogenesis, particularly in the CNS (Hernandez-Hernandez et al., 2013).
Similar articles
- Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies.
Schwartz JL, Jones KL, Yeo GW. Schwartz JL, et al. Crit Rev Biochem Mol Biol. 2021 Feb;56(1):31-53. doi: 10.1080/10409238.2020.1841726. Epub 2020 Nov 10. Crit Rev Biochem Mol Biol. 2021. PMID: 33172304 Free PMC article. Review. - RNA toxicity in non-coding repeat expansion disorders.
Swinnen B, Robberecht W, Van Den Bosch L. Swinnen B, et al. EMBO J. 2020 Jan 2;39(1):e101112. doi: 10.15252/embj.2018101112. Epub 2019 Nov 13. EMBO J. 2020. PMID: 31721251 Free PMC article. Review. - Repeat-associated non-ATG (RAN) translation.
Cleary JD, Pattamatta A, Ranum LPW. Cleary JD, et al. J Biol Chem. 2018 Oct 19;293(42):16127-16141. doi: 10.1074/jbc.R118.003237. Epub 2018 Sep 13. J Biol Chem. 2018. PMID: 30213863 Free PMC article. - RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.
Echeverria GV, Cooper TA. Echeverria GV, et al. Brain Res. 2012 Jun 26;1462:100-11. doi: 10.1016/j.brainres.2012.02.030. Epub 2012 Feb 22. Brain Res. 2012. PMID: 22405728 Free PMC article. Review. - 2D and 3D FISH of expanded repeat RNAs in human lymphoblasts.
Urbanek MO, Michalak M, Krzyzosiak WJ. Urbanek MO, et al. Methods. 2017 May 1;120:49-57. doi: 10.1016/j.ymeth.2017.04.002. Epub 2017 Apr 9. Methods. 2017. PMID: 28404480
Cited by
- Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1.
Hicks SM, Frias JA, Mishra SK, Scotti M, Muscato DR, Valero MC, Adams LM, Cleary JD, Nakamori M, Wang E, Berglund JA. Hicks SM, et al. Mol Ther Nucleic Acids. 2024 Sep 13;35(4):102338. doi: 10.1016/j.omtn.2024.102338. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39391766 Free PMC article. - Aberrant splicing exonizes C9ORF72 repeat expansion in ALS/FTD.
Yang S, Wijegunawardana D, Sheth U, Veire AM, Salgado JMS, Agrawal M, Zhou J, Pereira JD, Gendron TF, Guo JU. Yang S, et al. bioRxiv [Preprint]. 2023 Nov 14:2023.11.13.566896. doi: 10.1101/2023.11.13.566896. bioRxiv. 2023. PMID: 38014069 Free PMC article. Preprint. - Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster.
Marzullo M, Coni S, De Simone A, Canettieri G, Ciapponi L. Marzullo M, et al. Int J Mol Sci. 2023 Sep 16;24(18):14182. doi: 10.3390/ijms241814182. Int J Mol Sci. 2023. PMID: 37762484 Free PMC article. Review. - Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2.
Timchenko L. Timchenko L. Int J Mol Sci. 2022 Sep 10;23(18):10491. doi: 10.3390/ijms231810491. Int J Mol Sci. 2022. PMID: 36142405 Free PMC article. Review. - Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.
Liu J, Guo ZN, Yan XL, Yang Y, Huang S. Liu J, et al. Front Aging Neurosci. 2021 Nov 15;13:755392. doi: 10.3389/fnagi.2021.755392. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34867280 Free PMC article. Review.
References
- Arocena DG, et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Human Molecular Genetics. 2005;14:3661–3671. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous